Suspected adverse drug reactions of the type 2 antidiabetic drug class dipeptidyl-peptidase IV inhibitors (DPP4i): can polypharmacology help explain?

Lauren Jones, Alan M Jones

Research output: Working paper/Preprint › Preprint

Fingerprint

Dive into the research topics of 'Suspected adverse drug reactions of the type 2 antidiabetic drug class dipeptidyl-peptidase IV inhibitors (DPP4i): can polypharmacology help explain?'. Together they form a unique fingerprint.

Medicine & Life Sciences